Literature DB >> 19237523

Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer.

C Trollet1, Y Pereira, A Burgain, E Litzler, M Mezrahi, J Seguin, M Manich, M R Popoff, D Scherman, P Bigey.   

Abstract

Botulinum neurotoxins are known to be among the most toxic known substances. They produce severe paralysis by preventing the release of acetylcholine at the neuromuscular junction. Thus, new strategies for efficient production of safe and effective anti-botulinum neurotoxin antisera have been a high priority. Here we describe the use of DNA electrotransfer into the skeletal muscle to enhance antiserum titers against botulinum toxin serotypes A, B, and E in mice. We treated animals with codon-optimized plasmid DNA encoding the nontoxic but highly immunogenic C-terminal heavy chain fragment of the toxin. By employing both codon optimization and the electrotransfer procedure, the immune response and corresponding neutralizing antiserum titers were markedly increased. The cellular localization of the antigen and the immunization regimens were also shown to increase neutralizing titers to >100 IU/ml. This study demonstrates that DNA electrotransfer is an effective procedure for raising neutralizing antiserum titers to remarkably high levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237523      PMCID: PMC2681772          DOI: 10.1128/IAI.01269-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  The efficacy of electroporated plasmid vaccines correlates with long-term antigen production in vivo.

Authors:  Mark Miller; Greg Rekas; Kelley Dayball; Yong Hong Wan; Jonathan Bramson
Journal:  Vaccine       Date:  2004-06-30       Impact factor: 3.641

2.  Enhancement of DNA vaccine potency in rhesus macaques by electroporation.

Authors:  Gillis Otten; Mary Schaefer; Barbara Doe; Hong Liu; Indresh Srivastava; Jan zur Megede; Derek O'Hagan; John Donnelly; Georg Widera; Dietmar Rabussay; Mark G Lewis; Susan Barnett; Jeffrey B Ulmer
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

3.  Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters.

Authors:  Amit P Jathoul; Jane L Holley; Helen S Garmory
Journal:  Vaccine       Date:  2004-09-28       Impact factor: 3.641

Review 4.  Antitoxins: novel strategies to target agents of bioterrorism.

Authors:  G Jonah A Rainey; John A T Young
Journal:  Nat Rev Microbiol       Date:  2004-09       Impact factor: 60.633

5.  In vivo electroporation improves immune responses to DNA vaccination in sheep.

Authors:  J-P Y Scheerlinck; J Karlis; T E Tjelle; P J A Presidente; I Mathiesen; S E Newton
Journal:  Vaccine       Date:  2004-04-16       Impact factor: 3.641

6.  Genetic immunization is a simple method for eliciting an immune response.

Authors:  D C Tang; M DeVit; S A Johnston
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

Review 7.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

8.  Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland.

Authors:  Miia Lindström; Mari Nevas; Joanna Kurki; Raija Sauna-aho; Annikki Latvala-Kiesilä; Ilpo Pölönen; Hannu Korkeala
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.

Authors:  L Frelin; G Ahlén; M Alheim; O Weiland; C Barnfield; P Liljeström; M Sällberg
Journal:  Gene Ther       Date:  2004-03       Impact factor: 5.250

10.  Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.

Authors:  Mahmood Tavallaie; Alexandre Chenal; Daniel Gillet; Yannik Pereira; Maria Manich; Maryse Gibert; Stephanie Raffestin; Michel R Popoff; Jean Christophe Marvaud
Journal:  FEBS Lett       Date:  2004-08-13       Impact factor: 4.124

View more
  12 in total

1.  Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Authors:  R Zichel; A Mimran; A Keren; A Barnea; I Steinberger-Levy; D Marcus; A Turgeman; S Reuveny
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

2.  DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge.

Authors:  Veronica L Scott; Daniel O Villarreal; Natalie A Hutnick; Jewell N Walters; Edwin Ragwan; Khalil Bdeir; Jian Yan; Niranjan Y Sardesai; Adam C Finnefrock; Danilo R Casimiro; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Electroporation delivery of DNA vaccines: prospects for success.

Authors:  Niranjan Y Sardesai; David B Weiner
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

Review 4.  Technical transformation of biodefense vaccines.

Authors:  Shan Lu; Shixia Wang
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

5.  DNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and E.

Authors:  Aurore Burgain; Alice Rochard; Capucine Trollet; Christelle Mazuet; Michel R Popoff; Virginie Escriou; Daniel Scherman; Pascal Bigey
Journal:  Hum Vaccin Immunother       Date:  2013-07-22       Impact factor: 3.452

Review 6.  The future of human DNA vaccines.

Authors:  Lei Li; Fadi Saade; Nikolai Petrovsky
Journal:  J Biotechnol       Date:  2012-09-07       Impact factor: 3.307

Review 7.  Molecular mechanisms for enhanced DNA vaccine immunogenicity.

Authors:  Lei Li; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2015-12-28       Impact factor: 5.217

8.  Evaluation of a novel non-penetrating electrode for use in DNA vaccination.

Authors:  Amy Donate; Domenico Coppola; Yolmari Cruz; Richard Heller
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

Review 9.  Vaccines against Botulism.

Authors:  Grace Sundeen; Joseph T Barbieri
Journal:  Toxins (Basel)       Date:  2017-09-02       Impact factor: 4.546

Review 10.  Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.